1. Home
  2. BOXL vs GRI Comparison

BOXL vs GRI Comparison

Compare BOXL & GRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BOXL
  • GRI
  • Stock Information
  • Founded
  • BOXL 1985
  • GRI 2018
  • Country
  • BOXL United States
  • GRI United States
  • Employees
  • BOXL N/A
  • GRI N/A
  • Industry
  • BOXL Telecommunications Equipment
  • GRI Biotechnology: Pharmaceutical Preparations
  • Sector
  • BOXL Telecommunications
  • GRI Health Care
  • Exchange
  • BOXL Nasdaq
  • GRI Nasdaq
  • Market Cap
  • BOXL 3.9M
  • GRI 3.2M
  • IPO Year
  • BOXL 2017
  • GRI N/A
  • Fundamental
  • Price
  • BOXL $1.93
  • GRI $1.45
  • Analyst Decision
  • BOXL Buy
  • GRI Strong Buy
  • Analyst Count
  • BOXL 3
  • GRI 2
  • Target Price
  • BOXL $5.00
  • GRI $22.00
  • AVG Volume (30 Days)
  • BOXL 18.1K
  • GRI 110.3K
  • Earning Date
  • BOXL 08-06-2025
  • GRI 08-13-2025
  • Dividend Yield
  • BOXL N/A
  • GRI N/A
  • EPS Growth
  • BOXL N/A
  • GRI N/A
  • EPS
  • BOXL N/A
  • GRI N/A
  • Revenue
  • BOXL $121,223,000.00
  • GRI N/A
  • Revenue This Year
  • BOXL N/A
  • GRI N/A
  • Revenue Next Year
  • BOXL N/A
  • GRI N/A
  • P/E Ratio
  • BOXL N/A
  • GRI N/A
  • Revenue Growth
  • BOXL N/A
  • GRI N/A
  • 52 Week Low
  • BOXL $1.06
  • GRI $1.10
  • 52 Week High
  • BOXL $10.65
  • GRI $43.69
  • Technical
  • Relative Strength Index (RSI)
  • BOXL 59.54
  • GRI 51.99
  • Support Level
  • BOXL $1.72
  • GRI $1.20
  • Resistance Level
  • BOXL $1.89
  • GRI $1.45
  • Average True Range (ATR)
  • BOXL 0.13
  • GRI 0.10
  • MACD
  • BOXL 0.00
  • GRI 0.03
  • Stochastic Oscillator
  • BOXL 78.81
  • GRI 92.87

About BOXL Boxlight Corporation

Boxlight Corp is a technology company that develops, sells, and services interactive solutions predominantly for the education market but also for the corporate and government sectors. The company currently designs, produces, and distributes interactive technologies, including interactive and non-interactive flat panel displays, LED video walls, media players, classroom audio and campus communication, cameras, and other peripherals for the education market and non-interactive solutions including flat panels, LED video walls, and digital signage. The company also distributes science, technology, engineering, and math (or STEM) products, including 3D printing and robotics solutions and a portable science lab.

About GRI GRI Bio Inc.

GRI Bio Inc is a clinical-stage biotech company focused on discovering, developing, and commercializing therapies targeting serious diseases associated with dysregulated immune responses that to inflammatory, fibrotic, and autoimmune disorders. GRI Bio's program, GRI-0621, is a small molecule RAR-beta and gamma dual agonist that inhibits the activity of human NKT I cells, returning the immune system to homeostasis. It is also an oral formulation of tazarotene, a synthetic RAR-beta and gamma selective agonist for the topical treatment of psoriasis and acne. The company's other product candidate GRI-0803 is a novel oral agonist of type 2 Natural Killer T (type 2 NKT) cells which can be a potential treatment for autoimmune disorders.

Share on Social Networks: